Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Potential activity of Traditional Chinese Medicine against Ulcerative colitis: A review
Y Liu, Baoguo Li, Yuhua Su, et al.
Journal of Ethnopharmacology (2022) Vol. 289, pp. 115084-115084
Closed Access | Times Cited: 123
Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology
Snehlata Yadav, Ajay Sharma, Gulzar Ahmad Nayik, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 67
Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches
Qiang Sun, Ting Gong, Maolun Liu, et al.
Phytomedicine (2021) Vol. 94, pp. 153805-153805
Closed Access | Times Cited: 95
Natural shikonin and acetyl-shikonin improve intestinal microbial and protein composition to alleviate colitis-associated colorectal cancer
Hongyan Lin, Xiaopeng Ma, Xiaorong Yang, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109097-109097
Closed Access | Times Cited: 49
Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
Yaxi Zhou, Diandian Wang, Wenjie Yan
Nutrients (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 34
Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms
Yimeng Guo, Mingming Zhou, Zhenzhen Mu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115138-115138
Open Access | Times Cited: 21
Shikonin ameliorated mice colitis by inhibiting dimerization and tetramerization of PKM2 in macrophages
Bao-Yuan Huang, Qiumei Wang, Lin Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
So Shiho Tang Reduces Inflammation in Lipopolysaccharide-Induced RAW 264.7 Macrophages and Dextran Sodium Sulfate-Induced Colitis Mice
Mei He, Geonha Park, Do Hwi Park, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 451-451
Open Access | Times Cited: 2
Shikonin ameliorated LPS-induced acute lung injury in mice via modulating MCU-mediated mitochondrial Ca2+ and macrophage polarization
Baoyuan Huang, Lu Shu-Ru, Chen Le-xin, et al.
Phytomedicine (2024) Vol. 135, pp. 156043-156043
Closed Access | Times Cited: 2
Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies
Raju Das, Sarmin Ummey Habiba, Raju Dash, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3100-3100
Open Access | Times Cited: 7
Shikonin potentiates skin wound healing in Sprague–Dawley rats by stimulating fibroblast and endothelial cell proliferation and angiogenesis
Chenhong Xue, Jinfa Dou, Shuzhen Zhang, et al.
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access | Times Cited: 5
Combined Shikonin-Loaded MPEG-PCL Micelles Inhibits Effective Transition of Endothelial-to-Mesenchymal Cells
Guanglin Li, Chenxu Shang, Qingqing Li, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 4497-4508
Open Access | Times Cited: 8
Progress on Regulation of NLRP3 Inflammasome by Chinese Medicine in Treatment of Ulcerative Colitis
Hao-xian Sun, Ying Zhu
Chinese Journal of Integrative Medicine (2023) Vol. 29, Iss. 8, pp. 750-760
Closed Access | Times Cited: 4
“Shikonin inhibits microglia activation and reduces CFA-induced mechanical hyperalgesia in an animal model of pain”
Miguel Biscaia, Ricardo Llorente, José Gómez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112961-112961
Open Access | Times Cited: 6
Small Molecules Accelerate Skin Wound Healing: Shikonin Efficacy and Mechanism of Action in Mice
Jiaxin Liu, Lei Yang, Yu Wan, et al.
International Journal of Morphology (2024) Vol. 42, Iss. 1, pp. 127-136
Open Access
Shikonin ameliorates depressive- and anxiogenic-like behaviors in rats via the suppression of inflammation in the hippocampus
Cuijie Shi, Zihan Qi, Chang Yang, et al.
Neuroscience Letters (2024) Vol. 837, pp. 137893-137893
Closed Access
Research Progress on Mechanism of Shikonin in Treatment of Colitis
Mengmeng Zhang, Xuanhui Qu
Journal of Contemporary Medical Practice (2024) Vol. 6, Iss. 10, pp. 167-172
Open Access
Shikonin delivery nano system based on calcium alginate for targeted therapy of inflammatory bowel disease by modulating macrophage polarization
Min Yao, Mengjiao Ren, Wenxing Ding, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106336-106336
Closed Access
Bioavailability and Pharmacological Properties of Shikonin‐ A Phytocompound from Lithospermum Erythrorhizon
Stuti Biswal, Bijesh K. Biswal
ChemistrySelect (2024) Vol. 9, Iss. 45
Closed Access
Shikonin induces the apoptosis and pyroptosis of EGFR-T790M-mutant drug-resistant non-small cell lung cancer cells via the degradation of cyclooxygenase-2
Shiyu Cao, H. Li, Xiaoyan Ye, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Research Progress on Structure and Anti-Gynecological Malignant Tumor of Shikonin
Li-Na Ke, Ling-Qi Kong, Huanhuan Xu, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 2
Page 1

Scroll to top